Ethics and stem cell therapeutics for cardiovascular disease

被引:4
|
作者
Sugarman, Jeremy
机构
[1] Johns Hopkins Univ, Berman Inst Bioeth, Dept Med, Baltimore, MD 21205 USA
[2] Johns Hopkins Univ, Dept Hlth Policy & Management, Baltimore, MD 21218 USA
关键词
D O I
10.1016/j.pcad.2007.02.003
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
As research on stem cell therapeutics for the treatment of cardiovascular diseases in adults is being planned and conducted it is essential to address the ethical issues associated with it. The considerable attention that is currently focused on the ethical issues associated with stem cell research as well as the acute clinical situations sometimes encountered when treating cardiovascular disease, underscore the need for explicit attention to the ethical aspects of this research. In this article, I survey some of the key ethical considerations regarding research involving stem cell therapeutics for cardiovascular diseases including: (1) the standard ethical considerations for translational and clinical research and mechanisms of ethical oversight of them; (2) additional oversight related to stem cell research; (3) considerations for obtaining informed consent for this research and in selecting individual human subjects to participate in it; (4) concerns related to justice that may manifest themselves with respect to which research endeavors move forward and (5) conflicts of interest in research and their potential relationship to research integrity. © 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:1 / 6
页数:6
相关论文
共 50 条
  • [41] Ethics of stem cell storage
    Pinch, WJE
    AMERICAN JOURNAL OF NURSING, 1999, 99 (12) : 18 - 18
  • [42] Ethics of stem cell research
    Bahadur, G
    Proceedings of the 13th World Congress on In Vitro Fertilization, Assisted Reproduction & Genetics, 2005, : 587 - 593
  • [43] Leukotriene modifiers as potential therapeutics for cardiovascular disease
    Colin D. Funk
    Nature Reviews Drug Discovery, 2005, 4 : 664 - 672
  • [44] The ethics of stem cell research
    Morrissey, SR
    CHEMICAL & ENGINEERING NEWS, 2005, 83 (30) : 42 - 42
  • [45] Emerging stem cell ethics
    Sipp, Douglas
    Munsie, Megan
    Sugarman, Jeremy
    SCIENCE, 2018, 360 (6395) : 1275 - 1275
  • [46] Gender Dimorphisms in Progenitor and Stem Cell Function in Cardiovascular Disease
    Herrmann, Jeremy L.
    Abarbanell, Aaron M.
    Weil, Brent R.
    Manukyan, Mariuxi C.
    Poynter, Jeffrey A.
    Wang, Yue
    Coffey, Arthur C.
    Meldrum, Daniel R.
    JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH, 2010, 3 (02) : 103 - 113
  • [47] Autologous stem cell therapy in cardiovascular disease - Experiences in Dusseldorf
    Schannwell, C. M.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2008, 133 (50) : S274 - S279
  • [48] The haematopoietic stem cell niche: a new player in cardiovascular disease?
    Al-Sharea, Annas
    Lee, Man Kit Sam
    Purton, Louise E.
    Hawkins, Edwin D.
    Murphy, Andrew J.
    CARDIOVASCULAR RESEARCH, 2019, 115 (02) : 277 - 291
  • [49] Contemplating the bright future of stem cell therapy for cardiovascular disease
    Sánchez P.L.
    San Román J.A.
    Villa A.
    Fernández M.E.
    Fernández-Avilés F.
    Nature Clinical Practice Cardiovascular Medicine, 2006, 3 (Suppl 1): : S138 - S151
  • [50] Gender Dimorphisms in Progenitor and Stem Cell Function in Cardiovascular Disease
    Jeremy L. Herrmann
    Aaron M. Abarbanell
    Brent R. Weil
    Mariuxi C. Manukyan
    Jeffrey A. Poynter
    Yue Wang
    Arthur C. Coffey
    Daniel R. Meldrum
    Journal of Cardiovascular Translational Research, 2010, 3 : 103 - 113